These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8052186)

  • 21. A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli.
    Mahboudi F; Irina NA; Chevalier A; Ghadiri A; Adeli A; Amini-Bavil-Olyaee S; Barkhordari F; Farzamfar B; Alinejad M
    J Biotechnol; 2006 Sep; 125(2):295-303. PubMed ID: 16647775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory tests for HIV infection].
    Lipniacki A; Piasek A
    Przegl Lek; 2003; 60(7):478-84. PubMed ID: 14750423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV saliva test for surveillance and surveys.
    Wongba C; Pagcharoenpol P; Eskes N; Frerichs RR; Silarug N
    AIDS; 1995 Sep; 9(9):1104-5. PubMed ID: 8527089
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study on the seropositive prevalence of human immunodeficiency virus in a village residents living in rural region of central China].
    Cheng H; Qian X; Cao GH; Chen CK; Gao YN; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):317-21. PubMed ID: 15231200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Specificity of a new test for detection of antibodies to HIV-1/-2 in blood donors].
    Saadé C; Wüst T
    Infusionsther Transfusionsmed; 1996 Jun; 23(3):133-7. PubMed ID: 8924748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-positive HIV-1 p24 antigenemia with unusual pattern of neutralization.
    Barbouche RM; Bürgisser P; Slim A; Largueche B; Dellagi K
    Arch Inst Pasteur Tunis; 1999; 76(1-4):11-2. PubMed ID: 14666751
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiologic study of HIV serology among blood donors in the north-eastern region of France].
    Fabre G; Joussemet M; Vincent M
    Rev Fr Transfus Hemobiol; 1990 Jun; 33(3):223-5. PubMed ID: 2206169
    [No Abstract]   [Full Text] [Related]  

  • 29. Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1996; 10(4):213-9. PubMed ID: 8811465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-2 and HIV-1/2 seropositivity in Bihar.
    Saran R; Gupta AK
    Indian J Public Health; 1995; 39(3):119-20. PubMed ID: 8690492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HIV screening of pregnant women and blood donors].
    Lakartidningen; 1993 May; 90(19):1851. PubMed ID: 8502016
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-HIV seroprevalence in California blood and plasma donors.
    Perkins CI; Kizer KW; Hughes MJ; Holland PV; Lloyd JC
    West J Med; 1988 Nov; 149(5):620-2. PubMed ID: 3250108
    [No Abstract]   [Full Text] [Related]  

  • 33. Prozone effect with the VIDAS HIV DUO Ultra assay.
    Jnaoui K; Lamarti N; Pâques AT; Goubau P
    J Clin Virol; 2007 Mar; 38(3):273-4. PubMed ID: 17223608
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
    AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV antibody screening of blood donations 1987-1989.
    Wkly Epidemiol Rec; 1990 Oct; 65(43):330-1. PubMed ID: 2252864
    [No Abstract]   [Full Text] [Related]  

  • 37. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
    Malhotra R; Morgan DA
    Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p24 antigen and HIV screening.
    Lefrère JJ; Courouce AM; Rouger P; Duedari N; Elghouzzi MH
    Lancet; 1992 Apr; 339(8799):999-1000. PubMed ID: 1348838
    [No Abstract]   [Full Text] [Related]  

  • 39. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?
    Ly TD; Ebel A; Faucher V; Fihman V; Laperche S
    J Virol Methods; 2007 Jul; 143(1):86-94. PubMed ID: 17395277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV transmissions from a window-period platelet donation.
    Kopko PM; Fernando LP; Bonney EN; Freeman JL; Holland PV
    Am J Clin Pathol; 2001 Oct; 116(4):562-6. PubMed ID: 11601141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.